Hasegawa M - Search Results

1

The wound/burn guidelines - 3: Guidelines for the diagnosis and treatment for diabetic ulcer/gangrene.

Isei T, Abe M, Nakanishi T, Matsuo K, Yamasaki O, Asano Y, Ishii T, Ito T, Inoue Y, Imafuku S, Irisawa R, Ohtsuka M, Ohtsuka M, Ogawa F, Kadono T, Kodera M, Kawakami T, Kawaguchi M, Kukino R, Kono T, Sakai K, Takahara M, Tanioka M, Nakamura Y, Hashimoto A, Hasegawa M, Hayashi M, Fujimoto M, Fujiwara H, Maekawa T, Madokoro N, Yoshino Y, Le Pavoux A, Tachibana T, Ihn H; Wound/Burn Guidelines Committee. Isei T, et al. Among authors: hasegawa m. J Dermatol. 2016 Jun;43(6):591-619. doi: 10.1111/1346-8138.13285. Epub 2016 Mar 12. J Dermatol. 2016. PMID: 26972937

2

Effects of azelastin on pruritus and plasma histamine levels in hemodialysis patients.

Matsui C, Ida M, Hamada M, Morohashi M, Hasegawa M. Matsui C, et al. Among authors: hasegawa m. Int J Dermatol. 1994 Dec;33(12):868-71. doi: 10.1111/j.1365-4362.1994.tb01025.x. Int J Dermatol. 1994. PMID: 7883414 Clinical Trial.

3

The cutaneous reverse Arthus reaction requires intercellular adhesion molecule 1 and L-selectin expression.

Kaburagi Y, Hasegawa M, Nagaoka T, Shimada Y, Hamaguchi Y, Komura K, Saito E, Yanaba K, Takehara K, Kadono T, Steeber DA, Tedder TF, Sato S. Kaburagi Y, et al. Among authors: hasegawa m. J Immunol. 2002 Mar 15;168(6):2970-8. doi: 10.4049/jimmunol.168.6.2970. J Immunol. 2002. PMID: 11884469

4

Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis.

Sato S, Hayakawa I, Hasegawa M, Fujimoto M, Takehara K. Sato S, et al. Among authors: hasegawa m. J Invest Dermatol. 2003 Apr;120(4):542-7. doi: 10.1046/j.1523-1747.2003.12097.x. J Invest Dermatol. 2003. PMID: 12648215 Free article.

5

Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis.

Furuse S, Fujii H, Kaburagi Y, Fujimoto M, Hasegawa M, Takehara K, Sato S. Furuse S, et al. Among authors: hasegawa m. J Rheumatol. 2003 Jul;30(7):1524-8. J Rheumatol. 2003. PMID: 12858452

6

Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma.

Hasegawa M, Sato S, Nagaoka T, Fujimoto M, Takehara K. Hasegawa M, et al. Dermatology. 2003;207(2):141-7. doi: 10.1159/000071783. Dermatology. 2003. PMID: 12920362

7

Elevated circulating CD40L concentrations in patients with systemic sclerosis.

Komura K, Sato S, Hasegawa M, Fujimoto M, Takehara K. Komura K, et al. Among authors: hasegawa m. J Rheumatol. 2004 Mar;31(3):514-9. J Rheumatol. 2004. PMID: 14994397

8

Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells.

Sato S, Fujimoto M, Hasegawa M, Takehara K. Sato S, et al. Among authors: hasegawa m. Arthritis Rheum. 2004 Jun;50(6):1918-27. doi: 10.1002/art.20274. Arthritis Rheum. 2004. PMID: 15188368 Free article.

9

Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.

Sato S, Fujimoto M, Hasegawa M, Takehara K, Tedder TF. Sato S, et al. Among authors: hasegawa m. Mol Immunol. 2004 Nov;41(12):1123-33. doi: 10.1016/j.molimm.2004.06.025. Mol Immunol. 2004. PMID: 15482848 Review.

10

Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations.

Kodera M, Hayakawa I, Komura K, Yanaba K, Hasegawa M, Takehara K, Sato S. Kodera M, et al. Among authors: hasegawa m. J Rheumatol. 2005 Apr;32(4):629-36. J Rheumatol. 2005. PMID: 15801017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,208 results

Search Page

Filters